Thks Gnawkz for tabling in readable fashion the financing and the outflows.
So as not to mislead other investors, what meets the eyes is just a day in time. Looking at the 3Q '14 is likened to a HORROR show for financial analysts or any investor and is only for those knowing NWBO need upfront end loaded cash and survivability. I recall a similar situation no more than 7 yrs ago in San Diego of having serious cashflow issues, negative equity and on the verge of bankruptcy based solely on #: it finally got taken over by Big RX: I'll post when I recall.
With the badly needed $25 mln to fund NEW DCVAX L sites as well as initiating PH2 Direct and new indications for both indicates exception financial adroitness in overcoming monumental issues IMHO.
Mortgaging the Swanton UK facility indicates to me her conviction of success given her remarks today as well as those views of RRRichmond and therefore is a prudent use of very scarce resources as $10 mln goes a long way to furthering trials etc. Appears to be 50% down/50% mortgage.